Ransomware, IP & data theft top concerns for Indian pharma firms

Ransomware attacks and IP and data theft are the top cybersecurity concerns for pharma companies in India as they take the digital leap, a new report showed on Thursday.
The pandemic and a rising number of targeted attacks have prompted certain pharma companies to double their cybersecurity investments, according to the report by Deloitte India-Data Security Council of India (DSCI).
“To be able to scale this digital vision and create trust globally, the pharma sector must recognise cybersecurity as a key lever, working towards bolstering security around data, operational technologies (OT), and across the supply chain,” said Gaurav Shukla, Partner and Leader, Cyber, Deloitte India.